January 31, 2024
RegMed Investors (RMi) Closing Bell: When you are a cell and gene therapy believer, the benefit of the doubt is immeasurable – the sector is oversold
January 30, 2024
RegMed Investors (RMi) Closing Bell: What a tangled sector we invest, the cell and gene therapy universe
January 29, 2024
RegMed Investors (RMi) Closing Bell: volatility varies the share pricing risks to share pricing
January 26, 2024
RegMed Investors (RMi) Closing Bell: strapped-in for a rough ride
January 25, 2024
RegMed Investors (RMi) Closing Bell: the tug-of-war got tugged over the line
January 24, 2024
RegMed Investors (RMi) Closing Bell: Occam’s Razor
January 22, 2024
RegMed Investors (RMi) Closing Bell: got some
January 20, 2024
RegMed Investors (RMi) Closing Bell: glad the week is over; we need to review the oversold
January 18, 2024
RegMed Investors (RMi) Closing Bell: cell and gene therapy sector loses muscle strength while clinging to newest bottoms
January 17, 2024
RegMed Investors (RMi) Closing Bell: cell and gene therapy sector clings to newest bottoms
January 16, 2024
RegMed Investors (RMi) Closing Bell: rock-in the limbo dance
January 12, 2024
RegMed Investors (RMi) Closing Bell: a Friday’s opening jive followed by afternoon dive after 3-other weekly downfalls
January 11, 2024
RegMed Investors (RMi) Closing Bell: volatility rules
January 10, 2024
RegMed Investors (RMi) Closing Bell: the past curse as clinical and reimbursement risk is on the agenda reassessing 2024 expectations
January 9, 2024
RegMed Investors (RMi) Closing Bell: Volatility is high as selling/profit-taking amplified
January 8, 2024
RegMed Investors (RMi) Closing Bell: news from JPM Healthcare 2024 conference locks-in upside
January 5, 2024
RegMed Investors (RMi) Closing Bell: liquefying the sector from the pre-open thesis
January 4, 2024
RegMed Investors (RMi) Closing Bell: sector turnaround day as some value returns
January 3, 2024
RegMed Investors (RMi) Closing Bell: not feelin’ the love as algorithmic “instructions carry-out a specific order to perform a particular task”
January 2, 2024
RegMed Investors (RMi) Closing Bell: market trips, licensing news juices the cell and gene therapy sector for a while in session
December 29, 2023
RegMed Investors (RMi) Closing Bell: the last session’s hourglass slips empty
December 28, 2023
RegMed Investors (RMi) Closing Bell: The volatility tug-of-war
December 27, 2023
RegMed Investors (RMi) Closing Bell: a Santa Claus rally in a short week of pitstops
December 26, 2023
RegMed Investors (RMi) Closing Bell: holiday cheer is still with us as cell and gene therapy sector continues to cascade
December 22, 2023
RegMed Investors (RMi) Closing Bell: Happy Hanukkah, Merry Christmas and Holiday; travel safe
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors